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In 2017, the Interagency Autism Coordinating Committee (IACC), a federal advisory panel 
consisting of autism researchers and community members, recommended that funders of 
autism research prioritize research projects on: (1) treatments/interventions; (2) evidence-based 
services; and (3) lifespan issues. We sought to describe research funding since this 
recommendation was made. We searched the databases of the three largest federal funders of 
autism research in the United States (National Institutes of Health, Department of Education, 
and Centers for Disease Control and Prevention) for grants awarded during 2017-2019. We 
categorized grants as follows: autism screening and diagnosis, biology, risk factors, treatments 
and interventions, services, lifespan issues, or infrastructure and surveillance. We found that 
funding patterns remained largely consistent during 2017-2019. Biological research received a 
relative majority of funding (32.59%), followed by treatments and interventions (22.87%). While 
given higher funding priority by the IACC’s recent budget recommendation, fewer funds were 
awarded to research areas like services (5.02%) and lifespan issues (2.51%), indicating a 
misalignment between funding patterns and the IACC budget recommendation. These findings 
emphasize the need for autism research funding to align with the IACC budget 
recommendations to best meet the needs of the autism community, particularly autistic younger, 








In 2017, an advisory board consisting of autism researchers and community members 
recommended that funders of autism research prioritize research projects on: (1) 
treatments/interventions; (2) evidence-based services; and (3) lifespan issues. To describe 
funding in these areas since this recommendation was made, we searched the databases of the 
three largest federal funders of autism research in the United States. We found that the largest 
portion of federal funding during 2017-2019 was awarded to research on the biology of autism 
(32.59%) and treatments and interventions for autism (22.87%). Less funds were awarded to 
research areas that are high funding priorities by the IACC budget recommendation including 
services (5.02%), and lifespan issues (2.51%). Our findings emphasize that autism research 
funding is not consistent with the IACC budget recommendation to increase funding particularly 
to services and lifespan issues. We recommend that funding patterns should shift to better align 















Autism research funding in the United States (US) is largely informed by the Interagency 
Autism Coordinating Committee’s (IACC) Strategic Plan. The IACC is an advisory committee, 
consisting of federal agencies and public stakeholders, that coordinates federal activities and 
advises the Secretary of Health and Human Services on topics related to autism (IACC, 2017). 
IACC public stakeholders include researchers, service providers, autistic individuals who 
advocate for themselves, and family members of autistic individuals, who each bring different 
perspectives and expertise to priority setting for autism research (IACC, 2017). Priority research 
areas identified by the IACC include autism screening and diagnosis, biology, risk factors, 
treatments and interventions, services, lifespan issues, and infrastructure and surveillance.  
IACC’s most recent budget recommendation (IACC, 2017) stated that areas in particular 
need of funding were: (1) treatments/interventions; (2) evidence-based services; and (3) 
lifespan issues. Historically, studies in these priority areas have received only modest amounts 
of funding. For example, in 2016, treatments and interventions received only 16% of autism 
research funding, services received 5% of funding, and lifespan issues received 2% of funding 
(Office of Autism Research Coordination,(OARC) et al., 2019), with similar patterns observed in 
2014 (OARC et al., 2017). An Australian portfolio analysis of autism research funding found 
similar patterns concerning inadequate, or even no funding awarded to individual research 
areas, such as lifespan issues and infrastructure and surveillance (den Houting & Pellicano, 
2019). Funding in the United Kingdom is even more drastically skewed towards biological 
research (56% of funding), with services and lifespan issues research receiving only 6% of 
autism research funding combined (Pellicano et al., 2013).  
However, the extent to which recent US federal funding agencies have increased 
funding in these areas has not been studied. The purpose of this study, therefore, was to 
describe US federally funded autism research since this IACC recommendation was made. 
Understanding autism research federal funding patterns will help elucidate the extent to which 




 We searched the databases of the three largest US federal funders of autism research:  
National Institutes of Health (NIH), Department of Education (DoE), and Centers for Disease 
Control and Prevention (CDC) (IACC, 2016). We examined these funding agencies because 
they contain publicly available information about funded studies (including amount of funding 
awarded to each project), and they collectively award the majority (74%) of all autism research 
funding in the US (IACC, 2016). Information about grants funded during 2017-2019 was 
obtained from NIH RePorter, the Institute of Education Sciences, and the US Department of 
Health and Human Services’ Tracking Accountability in Government Grants System. Largely 
consistent with prior studies (den Houting & Pellicano, 2019), our search terms were: "autism" 
OR "autistic" OR "Asperger" OR "AUTS1" OR "AUTS2.” For the NIH, we searched for grants 
with a listed country of “United States and Territories,” and an award type of “new.” For the DoE, 
we searched the Institute for Education Sciences database entries listed as “grants;” database 
entries classified as “contracts” were excluded. Last, we searched the TAGGS database entries 
with a listed operating division of “CDC.”  
Grant Selection 
 Grants were eligible for inclusion in this analysis if they were newly funded during 
January 1st, 2017–December 31st, 2019. Grants that were initially funded before 2017 and were 
renewed during 2017-2019 were not included because: (1) grants funded before 2017 were 
included in the IACC’s prior Portfolio Analysis Reports on autism research spending; and (2) our 
objective was to understand the extent to which the most recent IACC Strategic Plan was used 
to inform funding expenditures since its publication.  
Next, the authors reviewed each grant to determine if the primary focus was autism. Two 
independent raters reviewed each grant's title, abstract, and scientific relevance (if available). 
The raters agreed on the inclusion or exclusion of 95% of the grants. In the event of a 
disagreement about whether or not a grant should be included (5%), a third independent rater 
reviewed the study to determine inclusion or exclusion. Our search strategy identified 1,268 
newly funded grants during 2017-2019. Of these, we identified 342 autism-focused grants. 
Grant Coding  
We coded grants according to the seven priority research areas identified by the 2016-
2017 IACC Strategic Plan: (1) diagnosis and screening; (2) biology; (3) risk factors; (4) 
treatments and interventions; (5) services; (6) lifespan issues; and (7) infrastructure and 
surveillance (IACC, 2017). We categorized grants into these seven priority research areas 
(OARC et al., 2017, 2019), similar to previous studies (den Houting & Pellicano, 2019; Pellicano 
et al., 2013). Each grant was coded by two blind raters. Our initial inter-rater agreement was 
65%. To resolve discrepancies, the team coded 20 grants together for calibration. Two raters 
then independently re-coded grants for which there was initially a lack of inter-rater agreement. 
After calibration, the inter-rater agreement was 91%. For the grants where the raters disagreed 
on the category (9%), a third, independent rater reviewed the grant and prior raters’ codes to 
determine the category.  
Analysis 
We performed descriptive analyses of the amount of research funding allocated to each 
IACC Strategic Plan priority area. The current analyses were based on cash investments only; 
in-kind contributions to autism research were not included.  
Community Involvement 
While this study was informed by prior findings on priority research areas identified by 
IACC autism community, this study was not a community-based participatory research project. 
Results 
 Table 1 describes the number of grants, total funding, and grant size for each IACC 
Strategic Plan priority area. The 342 grants totaled just over $159 million USD. Across the three 
years we examined, biological research received the largest amount of funding at 32.59% 
($51,884,400.00), while lifespan issues received the smallest amount at 2.51% ($3,992,400.00). 
The IACC priority areas of biology, treatments and interventions, and diagnosis and screening 
received the most funding during 2017-2019. Our analysis also revealed that while research in 
services received 5 more grants than infrastructure and surveillance, the total amount of funding 
awarded to services was less.  
Table 1 also shows the allocation of research funding in each IACC Strategic Plan 
priority area over time. Biology- and risk factors-focused research, combined, received 
approximately 50% of research funding in 2017 (55%) and 2018 (43%), and 37% in 2019. 
Treatments and interventions received approximately 20% of funds (18% in 2017; 19% in 2019), 
except in 2018, when 33% of funding was awarded. The increased funding of treatments and 
interventions research in 2018 was due to five large grants, totaling over $8.5 million 
collectively, awarded by the DoE. Research on services received small amounts of funding 
across all years examined (6% in 2017; 8% in 2018; 1% in 2019). Lifespan issues received no 
funding in 2017 and only 4% of research funding in 2018 and 2019.  
Discussion 
 We analyzed autism research funding patterns during 2017-2019 from the three largest 
federal funders of autism research in the US to examine the extent to which funding patterns 
align with the IACC’s budget recommendations. Our results were consistent with prior findings 
(OARC et al., 2017, 2019), indicating that biology-focused autism research received a relative 
majority of funding. Contributing to this pattern is the increase in biological research funding 
over other areas since 2008 (IACC, 2018). The IACC recommended an increase in funding to 
research on lifespan issues, services, and treatments and interventions. While treatments and 
interventions research received approximately 22.9% of autism research funding during the 
study period, funding awarded for lifespan issues and services research continues to be limited. 
We discuss our findings in these three priority areas below. 
 The IACC recommended increased funding for research on lifespan issues, and autistic 
individuals have also expressed a desire for increased research in this area (Frazier et al., 
2018; Roche et al., 2021). However, research on lifespan issues only comprised 2.51% of the 
autism research funding during 2017-2019. This finding highlights the misalignment between 
recent autism research funding and the IACC’s budget recommendations. As the number of 
autistic adults in the United States grows, there is an urgent need understand how to better 
meet this population’s needs. For example, there is a particular need to develop models of 
healthcare delivery for autistic adults, as they are significantly more likely to be diagnosed with 
most physical and mental health conditions than the general population (Hand et al., 2020). 
Transition-age youth in particular face a gap in service availability as they approach adulthood 
(Turcotte et al., 2016), in part due to a scarcity of trained adult healthcare practitioners who are 
willing and able to meet their needs (Morris et al., 2019). While the IACC’s strategic plan 
describes important lifespan issues work being done, such as employment programs for autistic 
individuals (IACC, 2018), further conversation is warranted to identify effective strategies to 
execute the IACC’s recommendation to increase funding in this priority area.  
Services research received only 5.02% of autism research funding during 2017-2019. 
This priority area includes studies to improve cost-effective service delivery, service utilization 
and access, and practitioner training to better meet the needs of autistic individuals (IACC, 
2017). In part, the amount of funding allocated to this priority area may be small because 
services studies may better fit within other priority areas. For example, research on healthcare 
services for autistic individuals as they age into and through adulthood would better fit under 
“lifespan issues.” Additionally, some studies that aim to increase use of services, like vocational 
rehabilitation or occupational therapy, may better fit under “treatments and interventions.”   
 In addition to lifespan issues and services, the IACC recommended an increase in funds 
allocated to treatments and interventions. Research on treatments and interventions received 
approximately 18-34% of total funding during 2017-2019. Grants in this area were awarded 16% 
of total autism research funds in 2016 (OARC et al., 2019), and increased to 33% in 2018; 
however, 2019 marked a decline in the funding allocated to this area (19% of autism research 
funds). This research category is critical for the development and testing of medications and 
interventions designed to help autistic individuals achieve their goals, which may ultimately lead 
to an improved quality of life and participation in valued activities. The variable amount of 
funding for this area in recent years may speak to a need for strategies to support sustained 
implementation of the IACC’s budget recommendations.  
Limitations 
Although our inclusion/exclusion and categorization procedures were conducted with 
three reviewers, they carry with them the possibility of bias. It possible that some grants could 
have been categorized differently, which would impact our results. Our initial inter-rater 
agreement was lower than expected (65%). Deciding whether to categorize grants as either risk 
factors or biology proved to be particularly challenging. Grants awarded to these areas often 
involved topics like biological and/or genetic mechanisms that made it hard to distinguish the 
focus of the grant. However, after we met as a group to re-calibrate our application of the 
categories, our inter-rater agreement rose to 91%. This is a commonly used procedure in 
studies that involve multiple raters categorizing research studies into mutually exclusive 
categories (Polanin et al., 2019).  
Since our data only includes newly funded grants while the IACC annual portfolio 
analysis includes both new and ongoing funding, our analysis may not be directly comparable to 
previous IACC analyses. Additionally, our search strategy did not identify all federally funded 
autism-focused grants in 2017-2019; while the IACC investigates 18 funders, we focused on the 
three largest federal funders of autism research in the US. Thus, we can be confident that the 
majority of federally funded autism research grants were included in our study.  
Conclusion 
 Federal autism research funding patterns from 2017-2019 have remained relatively 
consistent across priority areas, with an emphasis on biological research. There continues to be 
a misalignment between the types of studies that receive federal funding and the research 
areas deemed most in most need of funding by the IACC. Increased funding should be directed 
towards research areas prioritized by the IACC’s budget recommendation, including lifespan 
issues and development and delivery of evidence-based services, in order to advance research 
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Table 1: U.S. funding across IACC Strategic Plan categories during 2017-2019 
 
N = Number of Grants; IQR = Interquartile range 
 
*Reported in tens of thousands of USD, rounded to the nearest whole dollar. 
 
 
 2017  2018  2019  Total 



























                
Biology 52 2182 (37.9) 28 (20, 44)  42 1505 (34.1) 23 (8, 43)  39 1501 (26.1) 33 (9, 53)  133 5188 (32.6) 26 (15, 44) 
Treatments, 
Interventions 
24 1041 (18.1) 27 (21, 64)  22 1492 (33.8) 44 (18, 88)  15 1108 (19.3) 45 (22, 68)  61 3642 (22.9) 38 (21, 68) 
Risk Factors 27 1005 (17.4) 33 (24, 48)  11 388 (8.8) 38 (6, 57)  17 629 (11.0) 39 (23, 51)  55 2022 (12.7) 34 (21, 50) 
Diagnosis, 
Screening 
10 522 (9.1) 21 (14, 68)  15 405 (9.2) 20 (15, 37)  22 1233 (21.5) 50 (24, 77)  47 2159 (13.6) 25 (16, 73) 
Services 10 371 (6.4) 25 (20, 40)  9 357 (8.1) 22 (21, 47)  3 71 (1.2) 25 (20, 26)  22 799 (5.0) 25 (20, 40) 
Infrastructure, 
Surveillance 
6 643 (11.2) 39 (39, 163)  1 74 (1.7) 75 (75, 75)  10 993 (17.3) 84 (79, 109)  17 1711 (10.8) 84 (78, 114) 
Lifespan 
Issues 
0 0 (0) n/a  4 193 (4.4) 48 (22, 74)  3 206 (3.6) 61 (60, 86)  7 399 (2.5) 51 (25, 77) 
TOTAL 129 5764 (100) 29 (20, 48)  104 4414 (100) 25 (15, 51)  109 5741 (100) 44 (21, 72)  342 15920 (100) 33 (20, 60) 
